Stock Analiz

Actuate Therapeutics, Inc. (ACTU) stock forecast and price target

Price $0.29 · data as of November 13, 2026

12-month price target

Average target$11.68
Upside / downside+3995.1%
Analysts3
ConsensusNone
Low $8.00Average $11.68High $15.05

Gold marker: average target · white marker: today’s price ($0.29)

Analyst ratings

Strong buy 0Buy 3Hold 0Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-0.73+31.4%$0
Next fiscal year
ends December 31, 2027
$-0.66+8.7%$0
Next quarter
ends December 31, 2026
$-0.17+5.6%$0
Quarter after
ends March 31, 2027
$-0.17+29.2%$0

Consensus of the analysts covering Actuate Therapeutics, updated daily. In the last 30 days 1 estimates were raised and 1 lowered.

Frequently asked questions

What is the Actuate Therapeutics stock price target?

The average 12-month target from 3 analysts is $11.68, 3995.1% above the current price of $0.29 Targets range from $8.00 to $15.05.

Is Actuate Therapeutics a buy according to analysts?

The consensus rating is “None” (3 buy). Ratings are opinions, not guarantees; this is not investment advice.

How much is Actuate Therapeutics expected to earn?

Analysts expect EPS of $-0.73 for the fiscal year ending December 31, 2026 and $-0.66 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.